Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03854032
Recruitment Status : Recruiting
First Posted : February 26, 2019
Last Update Posted : April 12, 2019
Sponsor:
Information provided by (Responsible Party):
Thomas Jefferson University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2025
  Estimated Study Completion Date : December 2025